Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/Naloxone for OIC in Chronic Low Back Pain
NCT01427270Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Aug 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of oxycodone + naloxone in chronic low back pain (CLBP), opioid-induced constipation (OIC), sponsored by Purdue Pharma. Started Aug 2011; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
chronic low back pain (CLBP)opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01427270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01427270.